mRNA-1345

RSV Prevention: GSK and Moderna Lead the Way

GSKā€™s Arexvy and Modernaā€™s mRNA-1345 to lead the race for RSV prevention

SG Tylor

The respiratory syncytial virus (RSV) is a common cause of respiratory infections, especially in infants and older adults. It can ...

Moderna Submits Global Regulatory Applications for its RSV Vaccine, mRNA-1345 - USA Pharma News By Pharmtales

Moderna Submits Global Regulatory Applications for its RSV Vaccine, mRNA-1345

SG Tylor

Source – Moderna On July 5, 2023 Moderna, a biotech company at the forefront of mRNA vaccines, shared an update ...